The DOI matches its Crossref record; 434 of the 434 references it cites were found in a registry or an index.
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Abstract
Copper is a redox-active metal with many important biological roles. Consequently, its distribution and oxidation state are subject to stringent regulation. A large body of clinicopathological, circumstantial, and epidemiological evidence suggests that the dysregulation of copper is intimately involved in the pathogenesis of Alzheimer's disease. Other light transition metals such as iron and zinc may affect copper regulation by competing for copper binding sites and transporters. Therapeutic interventions targeting the regulation of copper are promising, but large gaps in our understanding of copper biochemistry, amyloidogenesis, and the nature of oxidative stress in the brain must be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–434 of 434
Yeung, P. S.-W., & Axelsen, P. H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3004478 · Cited by 35
Self-citationQuecksilber und Alzheimer-Erkrankung
Mutter, J., Naumann, J., Schneider, R., et al. (2007) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-959237 · Cited by 34
Hæffner, F., Smith, D. G., Barnham, K. J., & Bush, A. I. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.09.011 · Cited by 34
Alzheimer's Amyloid-β as a Preventive Antioxidant for Brain Lipoproteins
Kontush, A. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1012629603390 · Cited by 34
Bayer, T. A., & Multhaup, G. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8212 · Cited by 33
Squitti, R., & Polimanti, R. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111991 · Cited by 33
Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33
Giese, A., Buchholz, M., Herms, J. W., & Kretzschmar, H. A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:3:347 · Cited by 31
Substrate mediated reduction of copper-amyloid-β complex in Alzheimer’s disease
Streltsov, V. A., & Varghese, J. N. (2008) · Chemical Communications · doi:10.1039/b803911a · Cited by 31
Maiti, N. C., Jiang, D., Wain, A. J., Patel, S., Dinh, K. L., & Zhou, F. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp802038p · Cited by 31
Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients
Squitti, R., Quattrocchi, C. C., Forno, G. D., Antuono, P., Wekstein, D. R., Capo, C. R., Salustri, C., & Rossini, P. M. (2006) · Biomarker Insights · doi:10.1177/117727190600100019 · Cited by 30
Zhao, Y., Wang, Y., Hu, J., Zhang, X., & Zhang, Y.-W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330209 · Cited by 28
Komatsu, H., Feingold-Link, E., Sharp, K. A., Rastogi, T., & Axelsen, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165068 · Cited by 28
Self-citationSquitti, R., Quattrocchi, C. C., Forno, G. D., Antuono, P., Wekstein, D. R., Capo, C. R., Salustri, C., & Rossini, P. M. (2007) · PubMed Central · Cited by 27
Magni, F., Galbusera, C., Tremolada, L., Ferrarese, C., & Kienle, M. G. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.743 · Cited by 27
Oxysterol-Induced Rearrangement of the Liquid-Ordered Phase: A Possible Link to Alzheimer’s Disease?
Mitomo, H., Chen, W., & Regen, S. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904308y · Cited by 25
X-ray absorption and diffraction studies of the metal binding sites in amyloid β-peptide
Streltsov, V. A. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0232-5 · Cited by 25
Lipid Oxidation and Modification of Amyloid-β (Aβ) in vitro and in vivo
Ellis, G., Fang, E., Maheshwari, M., Roltsch, E. A., Holcomb, L. A., Zimmer, D. B., Martínez, D., & Murray, I. V. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100960 · Cited by 23
Gómez‐Balderas, R., Raffa, D. F., Rickard, G. A., Brunelle, P., & Rauk, A. (2005) · The Journal of Physical Chemistry A · doi:10.1021/jp050843i · Cited by 23
Hoogenraad, T. U. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/492686 · Cited by 23
da Silva, G. F. Z., Lykourinou, V., Angerhofer, A., & Ming, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.004 · Cited by 23
Age-related Oxidative Modifications of Proteins and Lipids in Rat Brain
Babušíková, E., Hatok, J., Dobrota, D., & Kaplán, P. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9314-0 · Cited by 22
Effects of cadmium, copper, and zinc on βAPP processing and turnover in COS-7 and PC12 cells
Smedman, M., Potempska, A., Rubenstein, R., Ju, W., Ramakrishna, N., & Denman, R. B. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815157 · Cited by 22
Involvement of the molecular chaperone Hspa5 in copper homeostasis in astrocytes
Qian, Y., Zheng, Y., Taylor, R., & Tiffany‐Castiglioni, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.065 · Cited by 22
Schiewe, A. J., Margol, L., Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032994.36343.02 · Cited by 19
Metal-Catalyzed Oxidative Damage and Oligomerization of the Amyloid-β Peptide of Alzheimer’s Disease
Ali, F. E. A., Barnham, K. J., Barrow, C. J., & Separovic, F. (2004) · Australian Journal of Chemistry · doi:10.1071/ch04026 · Cited by 18
Selective Cu2+/Ascorbate‐Dependent Oxidation of Alzheimer's Disease β‐Amyloid Peptides
Schöneich, C. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.013 · Cited by 18
Quantification of trans-4-hydroxy-2-nonenal enantiomers and metabolites by LC–ESI-MS/MS
Honzátko, A., BRICHAC, J., & Picklo, M. J. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.07.004 · Cited by 17
Copper(II) Coordination to Amyloid β: Murine versus Human Peptide
Eury, H., Bijani, C., Faller, P., & Hureau, C. (2010) · Angewandte Chemie · doi:10.1002/ange.201005838 · Cited by 15
Shimanouchi, T., Onishi, R., Kitaura, N., Umakoshi, H., & Kuboi, R. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2011.08.015 · Cited by 14
Copper catalysed oxidation of amino acids and Alzheimer's disease
Ali, F. E. A., Barnham, K. J., Barrow, C. J., & Separovic, F. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442571 · Cited by 13
An Electrospray Ionization Mass Spectrometric Study of Iron Binding to Amyloid-β Peptides
Drochioiu, G. (2009) · European Journal of Mass Spectrometry · doi:10.1255/ejms.1004 · Cited by 11
Dioxygen Activation by Biomimetic Dinuclear Complexes
Casella, L., & Gullotti, M. (1993) · Springer eBooks · doi:10.1007/978-94-011-6875-5_23 · Cited by 10
Schöneich, C., & Williams, T. D. (2003) · PubMed · Cited by 6
Cited by
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Metabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Amyloid Polymorphism: Structural Basis and Neurobiological Relevance
Tycko, R. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.017 · Cited by 440
Metadata
- Authors
- Eskici, G., & Axelsen, P. H.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-07-31
- Volume
- 51
- Issue
- 32
- Pages
- 6289-6311
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2073057315
- Cited by
- 290
- References
- 434
- FWCI
- 19.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.